Trial Profile
Clinical Trials Insight: 700030767
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2008
Price :
$35
*
At a glance
- Drugs Cethromycin (Primary) ; Moxifloxacin
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions; Registrational
- Sponsors Advanced Life Sciences
- 28 Oct 2008 Results have been presented at ICAAC/IDSA 2008.
- 25 Feb 2008 New trial record.